Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies
Elisabetta Bretto, Davide Giuseppe Ribaldone, Gian Paolo Caviglia, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2249-2249
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Cellular succinate metabolism and signaling in inflammation: implications for therapeutic intervention
Hong Huang, Gejing Li, Yini He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 20
Efficacy and safety of probiotics in IBD: An overview of systematic reviews and updated meta‐analysis of randomized controlled trials
María Manuela Estevinho, Yuhong Yuan, Iago Rodríguez‐Lago, et al.
United European Gastroenterology Journal (2024) Vol. 12, Iss. 7, pp. 960-981
Open Access | Times Cited: 12
Immunohistochemistry Analysis in Inflammatory Bowel Disease—Should We Bring to Light Interleukin-10?
Christopher Pavel, Mircea Diculescu, Mădălina Ilie, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 406-406
Open Access | Times Cited: 1
Therapeutic application and potential mechanism of plant-derived extracellular vesicles in inflammatory bowel disease
Jinling Li, Ting Luo, Dou Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 8
The Role of Gut Microbiota, Immune System, and Autophagy in the Pathogenesis of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutic Approaches
Beatrice Garavaglia, Letizia Vallino, Angela Amoruso, et al.
Aspects of Molecular Medicine (2024), pp. 100056-100056
Open Access | Times Cited: 7
Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches
Dingpei Long
Biomedicines (2024) Vol. 12, Iss. 3, pp. 689-689
Open Access | Times Cited: 4
The TL1A inhibitors in IBD: what’s in the pot?
F. Lusetti, Cristina Bezzio, A. De Bernardi, et al.
Expert Review of Gastroenterology & Hepatology (2025), pp. 1-11
Closed Access
Structural equation modeling of the impact of disease activity on inflammatory bowel disease control: the mediating roles of self-efficacy and self-management behaviors
Yongli Zhu, K Liu, Jinfeng Jiang, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Drug Development in Inflammatory Bowel Diseases: What Is Next?
Lorenzo Petronio, Arianna Dal Buono, Roberto Gabbiadini, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 190-190
Open Access
Strengths, weaknesses, opportunities, and threats analysis of combination therapy for inflammatory bowel disease
Yan Jin, Mei Nie, Hang Zhang, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 9
Closed Access
Beyond the beats: a systematic review of the underlying inflammatory pathways between atrial fibrillation and cognitive decline
Ana Mónica Machado, Ana Ferraz, M. Graça Pereira, et al.
Neurological Sciences (2025)
Open Access
Paradigm Shift in Inflammatory Bowel Disease Management: Precision Medicine, Artificial Intelligence, and Emerging Therapies
Antonio M.� Caballero-Mateos, Guillermo A. Cañadas‐De la Fuente, Beatriz Gros
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1536-1536
Open Access
Addressing Nutritional Knowledge Gaps in Inflammatory Bowel Disease: A Scoping Review
E Ribaudi, Shelly Amato, Guia Becherucci, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 833-833
Open Access
The 7436-bp mitochondrial DNA deletion as a risk factor for ulcerative colitis in the Iranian population
Rasoul Zahmatkesh Roodsari, Zivar Salehi, Kazem Parivar, et al.
Nucleosides Nucleotides & Nucleic Acids (2025), pp. 1-11
Closed Access
Gut Microbiota Metabolites and Chronic Diseases: Interactions, Mechanisms, and Therapeutic Strategies
Wen-Wen Liu, Lei Wang, Jinmei Ou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3752-3752
Open Access
Factors driving persistence to first-line advanced therapies in inflammatory bowel disease: a real-world study from a tertiary referral centre
Marco Vincenzo Lenti, Giovanni Santacroce, Federica Lepore, et al.
Internal and Emergency Medicine (2025)
Open Access
The Role of NKG2D and Its Ligands in Autoimmune Diseases: New Targets for Immunotherapy
Leiyan Wei, Zhiqing Xiang, Yizhou Zou
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17545-17545
Open Access | Times Cited: 9
Redox-sensitive hydrogel based on hyaluronic acid with selenocystamine cross-linking for the delivery of Limosilactobacillus reuteri in a DSS-induced colitis mouse model
Xi Lü, Mingming Fan, Yuzhe Ma, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 133855-133855
Closed Access | Times Cited: 2
Intestinal Membrane Function in Inflammatory Bowel Disease
Daisuke Nakai, Masateru Miyake
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 29-29
Open Access | Times Cited: 5
Effects and Mechanisms of the Xianhecao-Huanglian Drug Pair on Autophagy-Mediated Intervention in Acute Inflammatory Bowel Disease via the JAK2/STAT3 Pathway
Ya‐Ping He, Xin-Ling Shen, Haiyan Peng
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Effectiveness comparison between ustekinumab and infliximab for Crohn’s disease complicated with intestinal stenosis: a multicenter real-world study
Xidong He, Yufang Wang, Jingyao Sun, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 1
Mendelian randomization reveals predictive, preventive, and personalized insights into inflammatory bowel disease: the role of gut microbiome and circulating inflammatory proteins
Weiying Zhao, Shixiao Li, Qianqian Li, et al.
The EPMA Journal (2024) Vol. 15, Iss. 4, pp. 693-709
Closed Access | Times Cited: 1
The Dynamic Crosstalk between Gut Microbiota, Immune System, and Autophagy in the Onset of Inflammatory Bowel Disease: Molecular Mechanisms and Current Therapeutic Approaches
Beatrice Garavaglia, Letizia Vallino, Angela Amoruso, et al.
(2023)
Open Access | Times Cited: 1
SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1/Th2/Th17 induction and regulating the gut microbiota in mice
Fei Yang, Minjie Zhang, Ruyi Xu, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112234-112234
Closed Access
Machine Learning for Predicting Biologic Agent Efficacy in Ulcerative Colitis: An Analysis for Generalizability and Combination with Computational Models
Philippe Pinton
Diagnostics (2024) Vol. 14, Iss. 13, pp. 1324-1324
Open Access
Page 1 - Next Page

Scroll to top